List of bibliographic references
Number of relevant bibliographic references: 6.
List of associated KwdEn.i
Nombre de
documents | Descripteur |
|---|
| 4 | Humans |
| 3 | Antineoplastic Combined Chemotherapy Protocols (adverse effects) |
| 3 | Multiple Myeloma (drug therapy) |
| 2 | Aged |
| 2 | Antineoplastic Combined Chemotherapy Protocols (therapeutic use) |
| 2 | Bortezomib (administration & dosage) |
| 2 | Bortezomib (adverse effects) |
| 2 | Dexamethasone (administration & dosage) |
| 2 | Dexamethasone (adverse effects) |
| 2 | Disease-Free Survival |
| 2 | Female |
| 2 | Male |
| 2 | Multiple Myeloma (pathology) |
| 2 | Oligopeptides (administration & dosage) |
| 2 | Oligopeptides (adverse effects) |
| 1 | Adult |
| 1 | Anemia (chemically induced) |
| 1 | Antibodies, Monoclonal (therapeutic use) |
| 1 | Antiinflammatory agent |
| 1 | Antineoplastic Combined Chemotherapy Protocols (administration & dosage) |
| 1 | Antineoplastic agent |
| 1 | Bone Marrow Transplantation (methods) |
| 1 | Cause of Death |
| 1 | Consensus |
| 1 | Dexamethasone |
| 1 | Dose-Response Relationship, Drug |
| 1 | Drug Administration Schedule |
| 1 | Follow-Up Studies |
| 1 | Hematopoietic Stem Cell Transplantation (methods) |
| 1 | Human |
| 1 | Hypertension (chemically induced) |
| 1 | Immunologic Factors (therapeutic use) |
| 1 | Immunomodulator |
| 1 | Infusions, Intravenous |
| 1 | Internationality |
| 1 | Kaplan-Meier Estimate |
| 1 | Lenalidomide |
| 1 | Maximum Tolerated Dose |
| 1 | Medicine |
| 1 | Middle Aged |
| 1 | Multiple Myeloma (immunology) |
| 1 | Multiple Myeloma (mortality) |
| 1 | Multiple Myeloma (therapy) |
| 1 | Myeloablative Agonists (therapeutic use) |
| 1 | Myeloma |
| 1 | Neoplasm Recurrence, Local (drug therapy) |
| 1 | Neoplasm Recurrence, Local (mortality) |
| 1 | Neoplasm Recurrence, Local (pathology) |
| 1 | Neoplasm, Residual (chemically induced) |
| 1 | Neoplasm, Residual (diagnosis) |
| 1 | Pneumonia (chemically induced) |
| 1 | Practice Guidelines as Topic (standards) |
| 1 | Prognosis |
| 1 | Proportional Hazards Models |
| 1 | Prospective Studies |
| 1 | Proteasome Inhibitors (therapeutic use) |
| 1 | Randomized Controlled Trials as Topic |
| 1 | Recurrence |
| 1 | Remission Induction |
| 1 | Retreatment |
| 1 | Salvage Therapy (methods) |
| 1 | Survival Analysis |
| 1 | Survival Rate |
| 1 | Thrombocytopenia (chemically induced) |
| 1 | Transplantation Conditioning (methods) |
| 1 | Transplantation, Autologous |
| 1 | Transplantation, Homologous |
| 1 | Treatment Outcome |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Canada/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/Canada/Analysis/Author.i -k "Heinz Ludwig"
HfdIndexSelect -h $EXPLOR_AREA/Data/Canada/Analysis/Author.i \
-Sk "Heinz Ludwig" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Canada/Analysis/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= Canada
|étape= Analysis
|type= indexItem
|index= Author.i
|clé= Heinz Ludwig
}}
| This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024 |  |
